SC 13G/A

AMENDMENT NO. 6 TO THE SCHEDULE 13G

Company: Corvus Pharmaceuticals, Inc.
Filed: February 14, 2022
Accession Number: 0000921895-22-000439

View Document ↗ View on SEC.gov ↗